BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,974,000 | -42.6% | 75,230 | -33.4% | 0.01% | -36.4% |
Q2 2020 | $6,922,000 | -8.5% | 112,950 | -15.5% | 0.01% | -15.4% |
Q1 2020 | $7,564,000 | -14.4% | 133,702 | -13.8% | 0.01% | +30.0% |
Q4 2019 | $8,833,000 | +2.4% | 155,136 | -3.8% | 0.01% | 0.0% |
Q3 2019 | $8,628,000 | +27.1% | 161,217 | +41.8% | 0.01% | +25.0% |
Q2 2019 | $6,791,000 | +76.9% | 113,730 | +84.7% | 0.01% | +100.0% |
Q1 2019 | $3,838,000 | +33.6% | 61,583 | +29.9% | 0.00% | +33.3% |
Q4 2018 | $2,873,000 | +12.3% | 47,408 | +8.4% | 0.00% | +50.0% |
Q3 2018 | $2,558,000 | -42.8% | 43,727 | -56.1% | 0.00% | -60.0% |
Q2 2018 | $4,473,000 | -11.8% | 99,715 | -12.8% | 0.01% | 0.0% |
Q1 2018 | $5,071,000 | -13.6% | 114,376 | -15.6% | 0.01% | -16.7% |
Q4 2017 | $5,871,000 | +8.0% | 135,493 | +15.9% | 0.01% | 0.0% |
Q3 2017 | $5,437,000 | +19.0% | 116,867 | +26.6% | 0.01% | 0.0% |
Q2 2017 | $4,570,000 | +12.5% | 92,305 | +24.5% | 0.01% | +20.0% |
Q1 2017 | $4,064,000 | +33.3% | 74,159 | +35.5% | 0.01% | +25.0% |
Q4 2016 | $3,048,000 | +40.1% | 54,722 | +14.9% | 0.00% | +33.3% |
Q3 2016 | $2,175,000 | +36.5% | 47,632 | +19.4% | 0.00% | 0.0% |
Q2 2016 | $1,593,000 | +23.3% | 39,877 | +7.5% | 0.00% | +50.0% |
Q1 2016 | $1,292,000 | -9.6% | 37,106 | +11.6% | 0.00% | -33.3% |
Q4 2015 | $1,429,000 | -15.6% | 33,250 | -14.5% | 0.00% | 0.0% |
Q3 2015 | $1,693,000 | +12.9% | 38,897 | +33.9% | 0.00% | 0.0% |
Q2 2015 | $1,499,000 | +264.7% | 29,052 | +176.7% | 0.00% | +200.0% |
Q1 2015 | $411,000 | – | 10,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
UBS ASSET MANAGEMENT AMERICAS INC | 2,300 | $203,550,000 | 0.00% |